Your download is now in progress and you may close this window

Did you know that with a free Taylor & Francis Online account you can gain access to the following benefits?

Choose new content alerts to be informed about new research of interest to you
Easy remote access to your institution's subscriptions on any device, from any location
Save your searches and schedule alerts to send you new results
Export your search results into a .csv file to support your research

Have an account?
Login now Don't have an account?
Register for free

Login or register to access this feature

Have an account?
Login now Don't have an account?
Register for free

Choose new content alerts to be informed about new research of interest to you
Easy remote access to your institution's subscriptions on any device, from any location
Save your searches and schedule alerts to send you new results
Export your search results into a .csv file to support your research

Search in:

Advanced search

Journal of Drug Assessment Volume 2, 2013 - Issue 1

Journal homepage

Open access

946

Views

CrossRef citations to date

Altmetric

Original Article

In vitro evaluation of the effects of 4-aminopyridine on cytochrome P450 enzymes

Anthony CaggianoAcorda Therapeutics, Inc. Ardsley, NYUSA

Andrew BlightAcorda Therapeutics, Inc. Ardsley, NYUSACorrespondence[email protected]

Pages 106-116 | Accepted 19 Jun 2013, Published online: 26 Jun 2013

Cite this article
https://doi.org/10.3109/21556660.2013.818544

Full Article
Figures & data
References
Citations
Metrics
Licensing
Reprints & Permissions
View PDF PDF

Citations (4)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Articles from other publishers (4)

Kei Ikeda-Murakami, Naoto Tani, Tomoya Ikeda, Yayoi Aoki & Takaki Ishikawa. (2022) Central Nervous System Stimulants Limit Caffeine Transport at the Blood–Cerebrospinal Fluid Barrier. International Journal of Molecular Sciences 23:3, pages 1862.
Crossref

Eva Costa Arpín. (2020) Efficacy and safety of fampridine for walking disability in multiple sclerosis. Neurodegenerative Disease Management 10:5, pages 277-287.
Crossref

Dany Spaggiari, Youssef Daali & Serge Rudaz. (2016) An extensive cocktail approach for rapid risk assessment of in vitro CYP450 direct reversible inhibition by xenobiotic exposure. Toxicology and Applied Pharmacology 302, pages 41-51.
Crossref

Andrew R. Blight, Herbert R. HenneyIIIIII & Ron Cohen. (2014) Development of dalfampridine, a novel pharmacologic approach for treating walking impairment in multiple sclerosis. Annals of the New York Academy of Sciences 1329:1, pages 33-44.
Crossref

Share icon
Back to Top

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.

People also read
Recommended articles
Cited by

To cite this article:

Reference style: APA Chicago Harvard

Citation copied to clipboard

Reference styles above use APA (6th edition), Chicago (16th edition) & Harvard (10th edition)

Download citation

Download a citation file in RIS format that can be imported by citation management software including EndNote, ProCite, RefWorks and Reference Manager.

Choose format: RIS BibTex RefWorks Direct Export

Choose options: Citation Citation & abstract Citation & references